Learn about the newest therapies, interventions, and clinical research on multiple myeloma (MM). Cancer Nursing Today provides the latest clinical data and insights on screening for early detection, COVID-19 vaccine responses in patients with MM, and more. From treatment developments for relapsed/refractory MM and imaging techniques to the latest in CAR T-cell therapy, explore the latest outcomes in MM.
Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) study identified epidemiological and clinical characteristics of smoldering multiple myeloma (SMM) in a general population for the first time. Based on data from iStopMM’s 75,000 participant cohort, the study’s lead author, Sigrun Thorsteindotter, MD, PhD, and his team reported that the prevalence of SMM in persons aged 40 years or older is 0.53%. ...
The new data is being used to develop a biomarker tool to predict the efficacy of neoadjuvant pembrolizumab.
Many studies are examining COVID-19's impact on particular subgroups of patients with cancer.
Oncology nurses experience stress from many different directions—time pressures, nursing shortages, complex cancer ...